May 5, 2020 / 4:14 PM / a month ago

BRIEF-OSE Immunotherapeutics Announces Covid-19 Prophylactic Vaccine Program

May 5 (Reuters) - OSE IMMUNOTHERAPEUTICS SA:

* ANNOUNCES COVID-19 PROPHYLACTIC VACCINE PROGRAM

* FIRST PRECLINICAL RESULTS EXPECTED START OF H2 2020, POSSIBLE CLINICAL TRIAL BY YEAR END Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below